Large-scale analysis of B-cell epitopes on influenza virus hemagglutinin - Implications for cross-reactivity of neutralizing antibodies

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Sun, Jing ^a   Kudahl, Ulrich J ^a,b   Simon, Christian ^a,b   Cao, Zhiwei ^c   Reinherz, Ellis L ^a   Brusic, Vladimir ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c TONGJI UNIVERSITY   (China)

Author keywords

B cell epitope; Cross reactivity; Discontinuous peptide; Influenza virus; Neutralizing antibodies

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ARTICLE; B LYMPHOCYTE; BINDING SITE; BIOINFORMATICS; CROSS REACTION; INFLUENZA A; NONHUMAN; PHYLOGENETIC TREE; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

EID: 84895555369     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00038     Document Type: Article

References (49)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 289(2):179-86. doi: 10.1001/jama.289.2.179.
2. Parvin JD, Moscona A, Pan WT, Leider JM, Palese P. Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol (1986) 59(2):377-83.
3. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 324(5934):1557-61. doi:10.1126/science.1176062.
4. Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem (1987) 56:365-94. doi:10.1146/annurev.bi.56.070187.002053.
5. Nakamura G, Chai N, Park S, Chiang N, Lin Z, Chiu H, et al. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza a antibodies. Cell Host Microbe (2013) 14(1):93-103. doi:10.1016/j.chom.2013.06.004.
6. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, Haye K, et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio (2010) 1(1):e18-10. doi:10.1128/mBio.00018-10.
7. Okuno Y, Isegawa Y, Sasao F, Ueda S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol (1993) 67(5):2552-8.
8. Yoshida R, Igarashi M, Ozaki H, Kishida N, Tomabechi D, Kida H, et al. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. PLoS Pathog (2009) 5(3):e1000350. doi:10.1371/journal.ppat.1000350.
9. Ueda M, Maeda A, Nakagawa N, Kase T, Kubota R, Takakura H, et al. Application of subtype-specific monoclonal antibodies for rapid detection and identification of influenza A and B viruses. J Clin Microbiol (1998) 36(2):340-4.
10. Smirnov YA, Lipatov AS, Gitelman AK, Claas EC, Osterhaus AD. Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region. Arch Virol (2000) 145(8):1733-41. doi:10.1007/s007050070088.
11. Sakabe S, Iwatsuki-Horimoto K, Horimoto T, Nidom CA, Le M, Takano R, et al. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Res (2010) 88(3):249-55. doi:10.1016/j.antiviral.2010.09.007.
12. Ekiert DC, Wilson IA. Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol (2012) 2(2):134-41. doi:10.1016/j.coviro.2012.02.005.
13. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 16(3):265-73. doi:10.1038/nsmb.1566.
14. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science (2011) 333(6044):850-6. doi:10.1126/science.1205669.
15. Yamashita M, Krystal M, Fitch WM, Palese P. Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology (1988) 163(1):112-22. doi:10.1016/0042-6822(88)90238-3.
16. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 175(1):59-68. doi:10.1016/0042-6822(90)90186-U.
17. Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, Ekiert DC, et al. Highly conserved protective epitopes on influenza B viruses. Science (2012) 337(6100):1343-8. doi:10.1126/science.1222908.
18. Huang J, Honda W. CED: a conformational epitope database. BMC Immunol (2006) 7:7. doi:10.1186/1471-2172-7-7.
19. Squires RB, Noronha J, Hunt V, Garcia-Sastre A, Macken C, Baumgarth N, et al. Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza Other Respir Viruses (2012) 6(6):404-16. doi:10.1111/j.1750-2659.2011.00331.x.
20. Tsibane T, Ekiert DC, Krause JC, Martinez O, Crowe JE Jr, Wilson IA, et al. Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog (2012) 8(12):e1003067. doi:10.1371/journal.ppat.1003067.
21. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE Jr, Wilson IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science (2010) 328(5976):357-60. doi:10.1126/science.1186430.
22. Fleury D, Daniels RS, Skehel JJ, Knossow M, Bizebard T. Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins (2000) 40(4):572-8. doi:10.1002/1097-0134(20000901)40:4<::AID-PROT30>3.3.CO;2-E.
23. Ekiert DC, Kashyap AK, Steel J, Rubrum A, Bhabha G, Khayat R, et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature (2012) 489(7417):526-32. doi:10.1038/nature11414.
24. Whittle JR, Zhang R, Khurana S, King LR, Manischewitz J, Golding H, et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 108(34):14216-21. doi:10.1073/pnas.1111497108.
25. Schmidt AG, Xu H, Khan AR, O'Donnell T, Khurana S, King LR, et al. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A (2013) 110(1):264-9. doi:10.1073/pnas.1218256109.
26. Bizebard T, Gigant B, Rigolet P, Rasmussen B, Diat O, Bosecke P, et al. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature (1995) 376(6535):92-4. doi:10.1038/376092a0.
27. Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, Knossow M. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol (1999) 6(6):530-4. doi:10.1038/9299.
28. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, et al. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology (2002) 294(1):70-4. doi:10.1006/viro.2001.1320.
29. Lee PS, Yoshida R, Ekiert DC, Sakai N, Suzuki Y, Takada A, et al. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc Natl Acad Sci U S A (2012) 109(42):17040-5. doi:10.1073/pnas.1212371109.
30. Dreyfus C, Ekiert DC, Wilson IA. Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin. J Virol (2013) 87(12):7149-54. doi:10.1128/JVI.02975-12.
31. Throsby M, van den Brink E, Jongeneelen M, Poon LL, Alard P, Cornelissen L, et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 3(12):e3942. doi:10.1371/journal.pone.0003942.
32. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, et al. Antibody recognition of a highly conserved influenza virus epitope. Science (2009) 324(5924):246-51. doi:10.1126/science.1171491.
33. Ekiert DC, Friesen RH, Bhabha G, Kwaks T, Jongeneelen M, Yu W, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science (2011) 333(6044):843-50. doi:10.1126/science.1204839.
34. Sun X, Shi Y, Lu X, He J, Gao F, Yan J, et al. Bat-derived influenza hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a unique entry mechanism. Cell Rep (2013) 3(3):769-78. doi:10.1016/j.celrep.2013.01.025.
35. Larkin MA, Blackshields G, Brown NP, Chenna R, Mcgettigan PA, Mcwilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics (2007) 23(21):2947-8. doi:10.1093/bioinformatics/btm404.
36. Page RD. TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 12(4):357-8.
37. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res (2000) 28(1):235-42. doi:10.1093/nar/28.1.235.
38. Katz J, Hancock K, Veguilla V, Zhong W, Lu X, Sun H, et al. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep (2009) 58(19):521-4.
39. Stavitsky AB. Micromethods for the study of proteins and antibodies II. Specific applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells. J Immunol (1954) 72(5):368-75.
40. Yu X, Tsibane T, Mcgraw PA, House FS, Keefer CJ, Hicar MD, et al. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 455(7212):532-6. doi:10.1038/nature07231.
41. Krause JC, Tumpey TM, Huffman CJ, Mcgraw PA, Pearce MB, Tsibane T, et al. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol (2010) 84(6):3127-30. doi:10.1128/JVI.02184-09.
42. Katoh K, Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform (2008) 9(4):286-98. doi:10.1093/bib/bbn013.
43. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 25(17):3389-402. doi:10.1093/nar/25.17.3389.
44. Hubbard SJ, Thornton JM. Naccess. Computer Program. (Vol. 2). London: Department of Biochemistry and Molecular Biology, University College London (1993).
45. Mcconkey BJ, Sobolev V, Edelman M. Discrimination of native protein structures using atom-atom contact scoring. Proc Natl Acad Sci U S A (2003) 100(6):3215-20. doi:10.1073/pnas.0535768100.
46. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol (2007) 372(3):774-97. doi:10.1016/j.jmb.2007.05.022.
47. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 289(5796):366-73. doi:10.1038/289366a0.
48. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res (2004) 14(6):1188-90. doi:10.1101/gr.849004.
49. Olsen LR, Kudahl UJ, Simon C, Sun J, Schönbach C, Reinherz EL, et al. BlockLogo: Visualization of peptide and sequence motif conservation. J Immunol Methods (2013) 400:37-44. doi:10.1016/j.jim.2013.08.014.